Literature DB >> 20694010

The human cytomegalovirus microRNA miR-UL112 acts synergistically with a cellular microRNA to escape immune elimination.

Daphna Nachmani1, Dikla Lankry, Dana G Wolf, Ofer Mandelboim.   

Abstract

Although approximately 200 viral microRNAs are known, only very few share similar targets with their host's microRNAs. A notable example of this is the stress-induced ligand MICB, which is targeted by several distinct viral and cellular microRNAs. Through the investigation of the microRNA-mediated immune-evasion strategies of herpesviruses, we initially identified two new cellular microRNAs that targeted MICB and were expressed differently both in healthy tissues and during melanocyte transformation. We show that coexpression of various pairs of cellular microRNAs interfered with the downregulation of MICB, whereas the viral microRNAs optimized their targeting ability to efficiently downregulate MICB. Moreover, we demonstrate that through site proximity and possibly inhibition of translation, a human cytomegalovirus (HCMV) microRNA acts synergistically with a cellular microRNA to suppress MICB expression during HCMV infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20694010     DOI: 10.1038/ni.1916

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  47 in total

Review 1.  Role of microRNAs in plant and animal development.

Authors:  James C Carrington; Victor Ambros
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

2.  Identification and characterization of human cytomegalovirus-encoded microRNAs.

Authors:  Finn Grey; Andy Antoniewicz; Edwards Allen; Julie Saugstad; Andy McShea; James C Carrington; Jay Nelson
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 3.  Immunobiology of human NKG2D and its ligands.

Authors:  S González; V Groh; T Spies
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

4.  Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D.

Authors:  Gopalakrishnan M Venkataraman; Dominic Suciu; Veronika Groh; Jeremy M Boss; Thomas Spies
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

5.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing.

Authors:  Andrew Grimson; Kyle Kai-How Farh; Wendy K Johnston; Philip Garrett-Engele; Lee P Lim; David P Bartel
Journal:  Mol Cell       Date:  2007-07-06       Impact factor: 17.970

6.  MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells.

Authors:  Margaret S Ebert; Joel R Neilson; Phillip A Sharp
Journal:  Nat Methods       Date:  2007-08-12       Impact factor: 28.547

7.  Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D.

Authors:  Noam Stern-Ginossar; Chamutal Gur; Moshe Biton; Elad Horwitz; Moran Elboim; Noa Stanietsky; Michal Mandelboim; Ofer Mandelboim
Journal:  Nat Immunol       Date:  2008-09       Impact factor: 25.606

Review 8.  MicroRNAs in the Hox network: an apparent link to posterior prevalence.

Authors:  Soraya Yekta; Clifford J Tabin; David P Bartel
Journal:  Nat Rev Genet       Date:  2008-10       Impact factor: 53.242

Review 9.  Promiscuity and the single receptor: NKG2D.

Authors:  Robert A Eagle; John Trowsdale
Journal:  Nat Rev Immunol       Date:  2007-08-03       Impact factor: 53.106

10.  Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules.

Authors:  O Mandelboim; H T Reyburn; M Valés-Gómez; L Pazmany; M Colonna; G Borsellino; J L Strominger
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

View more
  88 in total

Review 1.  Viral miRNAs and immune evasion.

Authors:  Isaac W Boss; Rolf Renne
Journal:  Biochim Biophys Acta       Date:  2011-07-05

2.  Can we build it better? Using BAC genetics to engineer more effective cytomegalovirus vaccines.

Authors:  Mark R Schleiss
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

3.  Coordinated dysregulation of mRNAs and microRNAs in the rat medial prefrontal cortex following a history of alcohol dependence.

Authors:  J D Tapocik; M Solomon; M Flanigan; M Meinhardt; E Barbier; J R Schank; M Schwandt; W H Sommer; M Heilig
Journal:  Pharmacogenomics J       Date:  2012-05-22       Impact factor: 3.550

4.  The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack.

Authors:  Vu Thuy Khanh Le-Trilling; Ofer Mandelboim; Liat Dassa; Einat Seidel; Esther Oiknine-Djian; Rachel Yamin; Dana G Wolf
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

Review 5.  Cytomegalovirus microRNAs.

Authors:  Lauren Hook; Meaghan Hancock; Igor Landais; Robert Grabski; William Britt; Jay A Nelson
Journal:  Curr Opin Virol       Date:  2014-04-23       Impact factor: 7.090

Review 6.  Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.

Authors:  Mark R Schleiss
Journal:  Infect Disord Drug Targets       Date:  2011-10

7.  Up-regulation of microRNAs in brain of human alcoholics.

Authors:  Joanne M Lewohl; Yury O Nunez; Peter R Dodd; Gayatri R Tiwari; R Adron Harris; R Dayne Mayfield
Journal:  Alcohol Clin Exp Res       Date:  2011-06-08       Impact factor: 3.455

Review 8.  Herpesvirus Evasion of Natural Killer Cells.

Authors:  Steffi De Pelsmaeker; Nicolas Romero; Massimo Vitale; Herman W Favoreel
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

9.  HSV-1-encoded microRNA miR-H1 targets Ubr1 to promote accumulation of neurodegeneration-associated protein.

Authors:  Kai Zheng; Qiuying Liu; Shaoxiang Wang; Zhe Ren; Kaio Kitazato; Depo Yang; Yifei Wang
Journal:  Virus Genes       Date:  2018-03-14       Impact factor: 2.332

10.  Shaping of NK cell responses by the tumor microenvironment.

Authors:  Ana Stojanovic; Margareta P Correia; Adelheid Cerwenka
Journal:  Cancer Microenviron       Date:  2012-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.